Roger K. Cady
Corporate Officer/Principal at ALDER BIOPHARMACEUTICALS, INC.
Network origin in Roger K. Cady first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 29 | |
National Headache Foundation
3
| Non-Profit Organization | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Roger K. Cady via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | General Counsel | |
| EXELIXIS, INC. | Pharmaceuticals: Major | General Counsel | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INTERSECT ENT, INC. | Medical/Nursing Services | Director/Board Member | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder Founder | |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| PROCEPT BIOROBOTICS CORPORATION | Medical Specialties | Director/Board Member | |
| ATHIRA PHARMA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
| Wake Forest University | College/University | Doctorate Degree Doctorate Degree | |
Shearman & Sterling LLP
 Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Colgate University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Doctorate Degree | |
| Pepperdine University | College/University | Masters Business Admin | |
| Santa Clara University | College/University | Graduate Degree Masters Business Admin | |
| University of California, Irvine | College/University | Undergraduate Degree | |
| Washington Biotechnology & Biomedical Association | Director/Board Member Director/Board Member | ||
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor | |
| ALLERGAN PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Bausch & Lomb BV
 Bausch & Lomb BV Electronic ComponentsElectronic Technology Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life. It offers the world's most comprehensive portfolio of eye health products and the proud that it is one of the oldest, best known and most respected healthcare brands in the world. The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with nearly 14,000 employees worldwide, and with products available in more than 100 countries. | Electronic Components | Sales & Marketing | |
| Emory University School of Law | College/University | Graduate Degree | |
ALASTIN Skincare, Inc.
 ALASTIN Skincare, Inc. Household/Personal CareConsumer Non-Durables Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA. | Household/Personal Care | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | General Counsel | |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Founder Director/Board Member | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | General Counsel Chief Executive Officer Director of Finance/CFO | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| IMMATICS N.V. | Biotechnology | Director/Board Member | |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | General Counsel | |
| ADICET BIO, INC. | Pharmaceuticals: Major | General Counsel | |
| SATSUMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VYNE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 38 |
| United Kingdom | 4 |
| Canada | 4 |
| Ireland | 3 |
| Italy | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 11 |
| Finance | 3 |
| Commercial Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 159 |
| Corporate Officer/Principal | 81 |
| Independent Dir/Board Member | 63 |
| Undergraduate Degree | 29 |
| Chairman | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Vithalbhai Dhaduk | 36 |
| Heather Elizabeth Preston | 34 |
| Deepa Pakianathan | 32 |
| Stephen M. Dow | 20 |
| Wendy Yarno | 19 |
| Clay Siegall | 18 |
| Alan Montgomery | 18 |
| Robert Azelby | 15 |
| Eric Carter | 15 |
| Melissa Yeager | 12 |
| Paul Carter | 12 |
| Elisabeth Sandoval | 12 |
| Mark Litton | 11 |
| Jeremy Charles Green | 11 |
| Carlos Campoy | 10 |
- Stock Market
- Insiders
- Roger K. Cady
- Company connections
